Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIJ821 in Treatment-Resistant Depression
NCT03756129Phase 2Completed
- Sponsor
- Novartis
- Start
- Feb 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of onfasprodil in treatment-resistant depression (TRD), sponsored by Novartis. Started Feb 2019; status: completed.
02
Drugs
onfasprodil
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT03756129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03756129.